{"schema_version":"secwatch.filing_event.v1","accession":"0001823239-22-000052","form_type":"8-K","ticker":"MRVI","cik":"0001823239","company_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","filed_at":"2022-10-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.372131+00:00","generated_at":"2026-06-23T02:44:05.548886+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"CEO Trey Martin placed on paid leave after court-ordered noncompete TRO; Carl Hull named interim CEO","bullets":["Delaware Court of Chancery issued TRO preventing Martin from working for Maravai; pending preliminary injunction hearing later this year.","Danaher subsidiaries filed suit alleging Martin breached noncompete agreement from prior employment.","Carl Hull, former CEO and current Executive Chairman, appointed interim CEO to manage day-to-day operations.","Martin remains on paid leave with same compensation package pending resolution."],"urls":{"canonical":"https://secwatch.observer/filing/0001823239-22-000052","json":"https://secwatch.observer/filing/0001823239-22-000052.json","markdown":"https://secwatch.observer/filing/0001823239-22-000052.md","text":"https://secwatch.observer/filing/0001823239-22-000052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1823239/000182323922000052/0001823239-22-000052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1823239/000182323922000052/mrvi-20221018.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T02:44:05.548886+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"04147208b9","claim":"William \"Trey\" Martin, III departed as Chief Executive Officer at MARAVAI LIFESCIENCES HOLDINGS, INC..","evidence_excerpt":"On October 18, 2022, Maravai LifeSciences Holdings, Inc. (the “Company”) placed William “Trey” Martin, III, Chief Executive Officer, on a paid leave of absence following the issuance of a temporary restraining order by the Delaware Court of Chancery preventing him from working for the Company pending further order of the Court in a lawsuit filed against him by his previous employer alleging violation of a noncompetition agreement.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1823239/000182323922000052/0001823239-22-000052-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"placed on paid leave"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"eb5747dcdb","claim":"Carl Hull was appointed as Chief Executive Officer at MARAVAI LIFESCIENCES HOLDINGS, INC..","evidence_excerpt":"the Board of Directors (the “Board”) of the Company has appointed Carl Hull, Executive Chairman of the Board, to serve as interim Chief Executive Officer to maintain continuity of the day-to-day operations and draw upon his extensive knowledge of the management of the Company due to his prior service as the Company’s Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1823239/000182323922000052/0001823239-22-000052-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}